GH1 and hydrops fetalis: The alteration in the synthesis of the Growth Hormone (GH) and its peripheral effector insuline-like Growth Factor-1 (IGF-1) was documented in approximately 40–60% of HF patients [8]; on the other hand, the presence of a peripheral resistance to GH appears to be associated with the development of heart failure and cardiac cachexia [9].